Louis Picker, M.D., and his team have been awarded a $25 million grant from the Bill & Melinda Gates Foundation that will spur their work on a vaccine candidate against HIV. This work is based on previous findings that this candidate, which uses cytomegalovirus as a vector, can boost effector memory T cells to successfully target simian immunodeficiency virus. This new award will test the safety of a prototype human version of the vaccine in a phase I clinical trial in humans, as well as optimize the vaccine for phase II trials. Read the OHSU media release here, and here’s the Oregonian story.
Welcome to the Research News Blog
OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.
Recent Blog Posts
- OHSU and University of Oregon announce seed funding for collaborative research
- OHSU researchers raise concerns with applying the ProtecT Trial data to minority populations
- ScienceTalk ’18: Learn to communicate science to anyone, March 1–2
- Casey Williamson on ScienceTalk ’18: Learn to communicate science to anyone, March 1–2
- Denesa Oberbeck on ScienceTalk ’18: Learn to communicate science to anyone, March 1–2
- Tom Cooney on Advanced mapping and spatial reasoning tool for OHSU researchers
Awards Basic research Brown bag Cancer Career development Clinical research Collaboration Community Conference Cores Discoveries eIRB Event events Funding Funding focus funding opportunity Funding opportunity Graduate students Integrity Internal funding IRB notes Junior faculty Lecture Limited submission Neuroscience NIH NIH News OCTRI OHSU faculty OHSU Knight Cancer Institute OHSU researchers ONPRC Postdoctoral fellows Research Research administration Research integrity Research resources Research week Seminar Training Translational research TTBD Visiting speaker Workshop